Cencora (WBO:ABC) Tax Expense: €822 Mil (TTM As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
69 GF Score
Price €254.30
GF Value €259.48
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Tax Expense?

Cencora WBO:ABC -0.27% 69 Tax Expense is €822 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.48 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's tax expense for the months ended in Mar. 2026 was €397 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was €822 Mil.


Cencora  (WBO:ABC) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Cencora Tax Expense Related Terms


Cencora Tax Expense Historical Data

* Premium members only.

The historical data trend for Cencora's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Tax Expense Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 575.66 521.68 401.28 436.72 588.33

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.40 179.06 124.42 121.71 397.07
WBO:ABC
69GF Score
Cencora Inc WBO:ABC
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €822 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of €822 Mil mean?
Cencora (WBO:ABC) has a Tax Expense of €822 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Cencora and its competitors.
Is Cencora's Tax Expense too high?
Cencora's current Tax Expense is €822 Mil. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Tax Expense compare to CAH and MCK?
Cencora's Tax Expense of €822 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Distribution company?
A good Tax Expense depends on the Medical Distribution industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Cencora and its competitors. Cencora's current Tax Expense is €822 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.48, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current Tax Expense is €822 Mil. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Tax Expense is €822 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.48. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Tax Expense: €822 Mil
  • GF Value™: €259.48 vs. price of €254.30 (2% below fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score

Get the complete analysis for WBO:ABC

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€254.30
Price
€259.48
GF Value